FBIO Fortress Biotech, Inc.
Fortress Biotech, Inc. (FBIO) is expected to report earnings on November 12, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of +0.3% since its last earnings release on August 13, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Fortress Biotech, Inc.
Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.
Sector
Healthcare
Industry
Biotechnology